Φορτώνει......
Neoadjuvant endocrine therapy in breast cancer patients
HIGHLIGHTS: The overall response rate to neoadjuvant endocrine therapy (NET) was 54.55%. The eight patients proposed to tumour's downstage, after 9.71 months of NET, preserved their breast. In the group which achieved response, 10.28 months was the mean time to accomplish it. Even patients who...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Porto Biomed J |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Faculty of Medicine of the University of Porto
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6806912/ https://ncbi.nlm.nih.gov/pubmed/32258615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbj.2017.03.007 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|